Lorenz H. Lehmann

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 108 publications

MCL-1 inhibition triggers a largely reversible cardiac stress signature in a humanised mouse model.

MCL-1 inhibition triggers a largely reversible cardiac stress signature in a humanised mouse model.

Journal: British journal of pharmacology

Published: March 16, 2026

Costimulation Blockade Increases Risk of Ventricular Rupture in a Preclinical Model of Transmural Myocardial Injury.

Costimulation Blockade Increases Risk of Ventricular Rupture in a Preclinical Model of Transmural Myocardial Injury.

Journal: JACC. Basic to translational science

Published: March 06, 2026

Endovascular Diagnosis of Pulmonary Artery Intimal Sarcoma Using Intracardiac Echocardiography-Guided Biopsy.

Endovascular Diagnosis of Pulmonary Artery Intimal Sarcoma Using Intracardiac Echocardiography-Guided Biopsy.

Journal: JACC. Case reports

Published: March 05, 2026

HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity.

HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity.

Journal: Nature communications

Published: January 11, 2026

Circulating Musclin is associated with skeletal muscle function and subclinical cardiac dysfunction in patients with cancer.

Circulating Musclin is associated with skeletal muscle function and subclinical cardiac dysfunction in patients with cancer.

Journal: British journal of pharmacology

Published: December 05, 2025

Long-Term Mortality After PCI or CABG for Left Main Stem Disease: Updated Meta-Analysis of Randomized Trials Using Reconstructed Individual-Participant Survival Data.

Long-Term Mortality After PCI or CABG for Left Main Stem Disease: Updated Meta-Analysis of Randomized Trials Using Reconstructed Individual-Participant Survival Data.

Journal: Journal of the American College of Cardiology

Published: December 03, 2025

Transient cardiomyopathy by tyrosine kinase inhibitor therapy: time to define a new syndrome in cardio-oncology?

Transient cardiomyopathy by tyrosine kinase inhibitor therapy: time to define a new syndrome in cardio-oncology?

Journal: European heart journal

Published: December 02, 2025

Quality standards for preclinical research in cardio-oncology.

Quality standards for preclinical research in cardio-oncology.

Journal: European heart journal

Published: November 30, 2025

Cardiotoxic effects of BRAF/MEK inhibition: An observational study.

Cardiotoxic effects of BRAF/MEK inhibition: An observational study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 14, 2025

Prevalence of obstructive coronary artery disease in asymptomatic cancer patients with elevated troponin levels.

Prevalence of obstructive coronary artery disease in asymptomatic cancer patients with elevated troponin levels.

Journal: Cardio-oncology (London, England)

Published: October 13, 2025

Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial).

Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial).

Journal: European heart journal

Published: August 22, 2025

Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial).

Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial).

Journal: European heart journal

Published: August 22, 2025

Showing 1-12 of 108

Last Updated: 09/26/2026